| Original language | English |
|---|---|
| Article number | 2100979 |
| Pages (from-to) | 1-4 |
| Journal | The European respiratory journal |
| Volume | 58 |
| Issue number | 4 |
| Early online date | 25 Jun 2021 |
| DOIs |
|
| Publication status | Published - 1 Oct 2021 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The European respiratory journal, Vol. 58, No. 4, 2100979, 01.10.2021, p. 1-4.
Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review
TY - JOUR
T1 - Steroid use in elderly critically ill COVID-19 patients
AU - Jung, Christian
AU - Wernly, Bernhard
AU - Fjølner, Jesper
AU - Bruno, Raphael Romano
AU - Dudzinski, David
AU - Artigas, Antonio
AU - Pinto, Bernardo Bollen
AU - Schefold, Joerg C
AU - Wolff, Georg
AU - Kelm, Malte
AU - Beil, Michael
AU - Sigal, Sviri
AU - van Heerden, Peter Vernon
AU - Szczeklik, Wojciech
AU - Czuczwar, Miroslaw
AU - Elhadi, Muhammed
AU - Joannidis, Michael
AU - Oeyen, Sandra
AU - Zafeiridis, Tilemachos
AU - Marsh, Brian
AU - Andersen, Finn H
AU - Moreno, Rui
AU - Cecconi, Maurizio
AU - Leaver, Susannah
AU - Boumendil, Ariane
AU - De Lange, Dylan W
AU - Guidet, Bertrand
AU - Flaatten, Hans
N1 - Funding Information: Support statement: This work was supported by the European Commission, APHP and Health Region West (Norway). Funding information for this article has been deposited with the Crossref Funder Registry. Funding Information: Conflict of interest: C. Jung has nothing to disclose. B. Wernly has nothing to disclose. J. Fjølner has nothing to disclose. R.R. Bruno has nothing to disclose. D. Dudzinski has nothing to disclose. A. Artigas reports grants from Grifols and Fisher&Paykel, personal fees for advisory board work from Grifols, Novartis and Lilly Foundation, outside the submitted work. B. Bollen Pinto has nothing to disclose. J.C. Schefold has nothing to disclose. G. Wolff has nothing to disclose. M. Kelm has nothing to disclose. M. Beil has nothing to disclose. S. Sigal has nothing to disclose. P.V. van Heerden has nothing to disclose. W. Szczeklik has nothing to disclose. M. Czuczwar has nothing to disclose. M. Elhadi has nothing to disclose. M. Joannidis has nothing to disclose. S. Oeyen has nothing to disclose. T. Zafeiridis has nothing to disclose. B. Marsh has nothing to disclose. F.H. Andersen has nothing to disclose. R. Moreno has nothing to disclose. M. Cecconi has nothing to disclose. S. Leaver has nothing to disclose. A. Boumendil has nothing to disclose. D.W. De Lange has nothing to disclose. B. Guidet has nothing to disclose. H. Flaatten has nothing to disclose.
PY - 2021/10/1
Y1 - 2021/10/1
UR - http://www.scopus.com/inward/record.url?scp=85115877582&partnerID=8YFLogxK
U2 - 10.1183/13993003.00979-2021
DO - 10.1183/13993003.00979-2021
M3 - Comment/Letter to the editor
C2 - 34172464
SN - 0903-1936
VL - 58
SP - 1
EP - 4
JO - The European respiratory journal
JF - The European respiratory journal
IS - 4
M1 - 2100979
ER -